AlphaTuna
Posted - 6 days ago
Lowest Volume Rated General Stocks Per 11/15/2024’s Close:
1 – $BBSRF
2 – $VASO
3 – $VRDR
4 – $WVMDF
5 – $VLERF
6 – $ARESF
7 – $BREA
8 – $VSME
9 – $MTLFF
10 – $CNFN
https://optimizedvalue.xyz/daily-voltech-stock-etf-volume-technical-ratings-11-15-2024/
PenkeTrading
Posted - 2 weeks ago
I found you an Oversold RSI (Relative Strength Index) on the daily chart of Vaso Corp. Is that bullish or bearish? $VASO #Vaso #RsiOversold #OTCQB
BigCFinancial
Posted - 2 weeks ago
$VASO Wonder if this slips back to that 0.04-0.08 range wherenit was mired in for yrs...
BigCFinancial
Posted - 09/24/24
$VASO From Schwab news feed on dissolution with Achari
BigCFinancial
Posted - 09/24/24
$VASO hammered hard with dissolution of merger. Same language in recent Q about backlogged business and being seasonal. Still talking NASDAQ. Will need to do a R/s to meet listing requirements and then they will have to contend with MMs shorting them down and fighting that battle
Ron_Burn
Posted - 2 months ago
$VASO interesting... will keep watching her for now.
BigCFinancial
Posted - 2 months ago
$VASO NASDAQ listing is going to bring in an entirely new wave of retail shorting that current mgmt is NOT going to be prepared for.
hartSnyc
Posted - 2 months ago
$VASO On September 10, 2024, Vaso stockholders approved the Business Combination Proposal Proposal No. 1: The Business Combination Proposal For Against Abstain Broker Non-Votes
125,596,668 3.345,378 73,916 Based on the results of the Special Meeting, and subject to the satisfaction or waiver of certain other closing conditions as described in the Proxy Statement, the transactions contemplated by the Business Combination Agreement (the “Transactions”) are expected to be consummated promptly. Following the consummation of the Transactions, the common stock of Vaso after the completion of the Business Combination is expected to begin trading on the Nasdaq Stock Market LLC (the “Nasdaq”) under the ticker symbol “VASO” and the warrants of Vaso after the completion of the Business Combination are expected to trade on the Nasdaq under the ticker symbol “VASOW.”
hartSnyc
Posted - 2 months ago
$VASO
hartSnyc
Posted - 3 months ago
$VASO looks like $AVHI S-4 is near effective as VASO has filed preliminary 14A proxy already
I expect this transaction to close by end of August
$176m valuation is nearly $1.00 per share versus current $0.25 price
Pdisario
Posted - 3 months ago
$AVHI $VASO can someone find out what is next step
BigCFinancial
Posted - 07/30/24
$VASO $28M Thats pretty much the story in a nutshell. Great job with GEHC and theyve been squandering the cash ever since. EVERY M&A they did since was supposed to be accretive yet none of them have yet to contribute positively to bottom line while the company is still being held above water by the GEHC relationship (which could disappear any minute). He completely.bungled the EECP flagship & advantage and rather than move forward fromnthe failed PEECH clinical trials where they couldn't identify WHY it worked (later they did tying it to endothileal fx), they pivoted to a "healthcare" co. NetWolves destroyed their cash reserves & still remains very unprofitable and still no, real integration with their other businesses (like Biox).
$AVHI RM supposed to be completed in 2Q24. Almost a full month after and nothing communicated.
Minnyankee
Posted - 5 months ago
$VASO Ma did a good job five years ago in developing the relationship with GE, now GEHC, so the company remained solvent. He has done nothing since. The company is sitting on $28M plus and won't reinvest this money back into the company. That's not a sign of confidence for shareholders. They have totally butchered the potential merger, and their silence regarding the merger speaks volumes. Another reflection of the ineptitude of management was the Netwolves purchase. It was done to benefit one of their own, and the ancillary business is a distraction and does not add to the bottom line. In fact, it hurts the bottom line. Management has outgrown its usefulness. It's time to part company and hire a visionary. Did I mention that the business model sucks. Tying your finances as a sales agent for another company's products is dangerous. Lose the relationship with the parent company and you are looking at bankruptcy. No innovative product or service equals a penny stock doomed for failure.
BigCFinancial
Posted - 05/29/24
$VASO https://www.otcmarkets.com/stock/VASO/news/Vaso-Corporation-a-Diversified-Medical-Technology-Company-Currently-Trading-on-the-OTCQX-Market-to-List-on-Nasdaq-via-SP?id=424107
No update since this was announced.
$AVHI currnt MC is $33MM. Deal values Vaso @ $170MM tho it wasnt broken down beyond that. VASO mgmt has never figured out how to integrate the last 5-7 yrs of M&A activity to be profitable & Netwolves acquisition still doesnt seem to be profitable even tho that acquisition was claimed to be immediately accretive.
Pdisario
Posted - 05/27/24
$VASO not looking good.. Achari shares have been suspended
Skinnyvinny
Posted - 6 months ago
$VASO what happen to the merger? (Dec news)
algomezus
Posted - 7 months ago
$VASO some motion in the ocean.
BigCFinancial
Posted - 9 months ago
$VASO Interesting how much is being attributed to Covid shots causing endothileal inflammation. Early PEECH trials for EECP showed dramatic improvement in O2 uptake/quality of life that was well beyond invasive heart surgery. https://www.jacc.org/doi/10.1016/j.jacc.2005.10.079
The trial never gained traction/wasn't accepted by ACA due to lack of knowing mechanism and got shut down during peer review for such. Wasn't until sev years later that it was attributed to endothileal function but VASO never went on to do clinical trials to prove this and validate PEECH results:
https://www.medscape.com/viewarticle/544941?form=fpf
With so many signs pointing to the Covid shots leading to myocardial inflammation which is being linked back to endothileal inflammation - wonder if EECP would assist those identified with this damage from the shots or the "long Covid" which is tied to respiratory issues around O2 uptake.
I was a large investor in VASO for a long time for EECP & eventually 1/2
EarningsInsider
Posted - 01/25/24
Vaso Sees Short Interest Decrease from 19,600 shares to 6,600 shares. $VASO https://www.marketbeat.com/stocks/OTCMKTS/VASO/short-interest/
EarningsInsider
Posted - 11 months ago
Vaso Sees Short Interest Decrease from 8,800 shares to 5,600 shares. $VASO https://www.marketbeat.com/stocks/OTCMKTS/VASO/short-interest/
BigCFinancial
Posted - 11 months ago
@cctranscripts $VASO here is Form 4
See footnote
BigCFinancial
Posted - 11 months ago
$VASO that is incorrect. Markowitz simply is consolidating bus Holdings into one entity - probably for eventual CIC with RM.
cctranscripts
Posted - 11 months ago
Vasomedical insider just picked up 55,738,318 shares https://www.conferencecalltranscripts.org/summary/?id=12780976 $VASO
joker777
Posted - 11 months ago
$VASO 2024 is gonna make 2021 look like 2020!!
BigCFinancial
Posted - 11 months ago
@seriy34 $10/sh gives $VASO MC well over $2BB fully diluted (based on 185OS and Preferred).
They do $80MM in revs which a large chunk is nothing but distribution for GEHC. That is also the ONLY part of the business that is profitable and has been carrying the co since they failed the PEECH trials. That agreement goes away-its nothing but a loosely tied collection of businesses that lose money and never have been able to profitably integrate/ramp up despite almost every acquisitions the company made was claimed to be accretive (specifically Netwolves & Biox).
Where is the real value in those businesses? What can be done differently to make them profitable? What is the business worth w/o the GEHC agreement that could disappear at any time?
At most, based on the history, someone may buy the revs assuming they can make them consistently profitable which would be $0.85-0.95/sh. Even then- that's putting a LOT of risk in keeping GEHC agreement
BigCFinancial
Posted - 11 months ago
$VASO $10/share...?
Based on what?
seriy34
Posted - 11 months ago
$VASO this should be fun
cctranscripts
Posted - 11 months ago
Vasomedical: Vaso Corporation, A Diversified Medical Technology Company Currently Trading On Th https://www.conferencecalltranscripts.org/summary/?id=12776027 $VASO
